What is a Dermatology Fractional CFO?
A fractional CFO for dermatology practices provides strategic financial leadership for growing derm groups — covering medical vs. cosmetic portfolio strategy, private equity readiness, and multi-location expansion — typically engaged by dermatologist-owners generating $3M–$20M who want to maximize practice value.
That $400K laser looks great in the brochure. What does it look like in your financials?
Strategic financial guidance for dermatologist-owners making equipment, staffing, and growth decisions with real ROI analysis.
A 4-minute test your accountant hopes you skip.
At a glance
Industry Context
The Strategic Picture for Dermatology Practices
Dermatology is one of the most profitable specialties in medicine when run well, and one of the most consolidated. Private equity-backed dermatology platforms (Anne Arundel Dermatology, Forefront, USDP, Schweiger, Pinnacle, others) have rolled up thousands of practices over the last decade at multiples that have ranged from 8 to 14 times EBITDA depending on size, growth, and cosmetic mix. A practice with strong cosmetic volume and proven Mohs throughput commands a premium; a Medicare-heavy general derm practice does not.
The CFO conversation in dermatology is rarely about cutting costs. It is about capital allocation: should you buy or lease a new laser platform, should you bring pathology in-house or outsource to a derm-pathology lab, should you hire a Mohs surgeon as a partner or as W-2, should you add a med spa wing or build out a separate brand. Each of these decisions involves seven-figure capital commitments and ten-year cash flow implications. A fractional CFO models them with realistic case volumes and reimbursement assumptions specific to dermatology.
Is This Right for You?
This service is for dermatology practice owners facing these challenges:
Need accurate books first? Our Accounting service for dermatology practices may be a better starting point.
Strategic Pitfalls
CFO-Level Mistakes We See in Dermatology Practices
The strategic and capital-allocation errors that cost dermatology practice owners the most.
01
Treating the cosmetic side as a 'side hobby'
In many derm practices, cosmetic operations are run informally because the clinical work generates the bulk of insurance revenue. But cosmetic typically has 60 to 75 percent gross margins versus 35 to 50 percent for medical, and a properly run cosmetic operation can be the highest-margin part of the business.
02
Buying lasers based on the salesperson's volume model
Laser and aesthetic device companies (Cynosure, Cutera, Lumenis, Sciton) sell on optimistic case volume assumptions. A $300K device that requires 800 cases per year to break even may realistically only get 300 cases in a typical practice. Independent ROI modeling is essential.
03
Hiring an associate without modeling Mohs throughput
A Mohs surgeon can generate $1.5M to $3M in collections annually depending on volume and case mix, but the rooms, histology techs, and scheduling structure required to support that throughput are often underestimated. Adding a Mohs surgeon without the operational capacity to support them is a common mistake.
04
Underpricing cosmetic procedures
Cosmetic pricing in dermatology is market-driven, not cost-driven. Many practices price Botox or fillers at the low end of their market because they are uncomfortable charging more, leaving 15 to 30 percent of margin on the table. A pricing analysis usually shows room to raise prices without losing significant volume.
05
Not negotiating drug acquisition costs
Group purchasing organizations and direct manufacturer contracts can reduce biologic and injectable costs by 5 to 12 percent. On a practice spending $500K per year on these drugs, that is $25K to $60K of straight margin recovery.
The Numbers That Matter
CFO Dashboard Metrics for Dermatology Practices
Adjusted EBITDA
- Earnings before interest, taxes, depreciation, and amortization with owner compensation normalized.
EBITDA Margin
Healthy range: 20 to 35 percent for well-run practices
- Adjusted EBITDA as a percentage of collections. Drives PE and consolidator valuations.
Cosmetic Contribution Margin
Healthy range: 40 to 55 percent
- Cosmetic gross margin minus directly attributable cosmetic staff and overhead.
Mohs Cases per Surgeon per Day
Healthy range: 8 to 14 cases per day
- Average completed Mohs cases per surgical day. Drives capacity planning.
Equipment Utilization Rate
Healthy range: 50 percent or higher to justify ownership
- Hours of laser or device use divided by available hours, per device.
New Patient Acquisition Cost
Healthy range: $80 to $200 medical, $150 to $400 cosmetic
- Marketing spend divided by new patients (separate cosmetic from medical).
Provider Productivity Index
- Collections per provider divided by clinical hours, normalized across providers for capacity planning.
Capital & Vendor Strategy
Equipment, Software, and Partner Decisions
From a CFO perspective, equipment vendor relationships drive a large portion of capital decisions. Laser vendors (Cynosure, Cutera, Sciton, Lumenis) have aggressive financing packages and trade-in programs that look attractive on paper but obscure the realistic ROI. Devices in the $150K to $500K range need to be evaluated against actual case volume the practice can support, not the vendor's optimistic projections.
When a practice is preparing for a sale or recap, the choice of EMR matters. ModMed and Nextech have native multi-location reporting that makes diligence faster. Older practices on legacy systems often need to invest 3 to 6 months in data cleanup and reporting infrastructure before a serious buyer will engage at full value. Skincare product distributor relationships (SkinMedica, ZO Skin Health, Alastin, Obagi) also affect cosmetic margins, and the contract terms vary widely between brands.
What's Included
How a Fractional CFO Works for Dermatology Practices
Dermatology-specific strategic leadership that goes beyond reporting.
Service Line Strategy
- •Medical vs cosmetic revenue optimization
- •New cosmetic service ROI modeling (body contouring, laser resurfacing)
- •Medical dermatology growth opportunities (biologics, clinical trials)
Equipment & Capital Investment
- •Laser and device ROI analysis with utilization projections
- •Lease vs purchase analysis for high-cost equipment
- •Equipment replacement planning and reserve funding
- •Break-even utilization rates per device
Expansion & M&A
- •Practice valuation with dermatology-specific multiples
- •PE/MSO offer analysis and negotiation
- •Satellite location feasibility (medical vs cosmetic focus)
Mid-Level Provider Strategy
- •PA/NP financial modeling (revenue ramp, supervision costs)
- •Compensation structure design (salary vs production-based)
- •Optimal provider mix analysis
Results
What Dermatology Practices Experience
| Metric | Typical Outcome |
|---|---|
| Cosmetic margin improvement | $150K–$200K range annually from margin analysis, pricing corrections, and filler waste reduction |
| Mohs revenue recovered | Mid-five figures from coding corrections |
| Mid-level restructuring | Both providers became profitable within a quarter or two once the schedule was optimized |
Illustrative Scenario
What This Looks Like In Practice
A multi-physician dermatology practice with a cosmetic suite, single location, several million in annual revenue. Revenue had grown in the high teens as a percentage over a few years while net income stayed flat. The owner could not explain the gap.
What we typically find:
- •Cosmetic generating roughly a third of revenue but closer to a fifth of profit, driven by untracked filler waste in the low double digits per vial and under-priced laser treatments
- •Mohs multi-stage cases being billed as single-stage a meaningful share of the time, leaving mid-five-figure revenue uncollected annually
- •Mid-level providers showing as revenue generators on the surface but net-negative once supervision time, benefits, and overhead were properly allocated
- •A membership program with a high utilization rate that meant the practice was effectively giving away five figures in unused services a year
Representative results
$150K–$200K range annually from margin analysis, pricing corrections, and filler waste reduction
Cosmetic margin improvement
Mid-five figures from coding corrections
Mohs revenue recovered
Both providers became profitable within a quarter or two once the schedule was optimized
Mid-level restructuring
The takeaway
The pattern we see in dermatology practices with meaningful cosmetic volume: without provider-level and service-level margin tracking, cosmetic often looks better than it really is on a loaded-cost basis, while the quieter medical side is doing the actual work.
Think your dermatology practice has similar potential?
Common Questions About Fractional CFO for Dermatology Practices
Stop guessing. Start leading your dermatology practice with data.
Take the 4-minute financial assessment—and find out if your dermatology practice is ready for strategic CFO leadership.
The test your accountant hopes you skip.
By state
Dermatology Practices accounting and CFO support, by state
State-level tax, payer, and regulatory context shapes what “good” looks like for dermatology practices practices. The pages below walk through each state's specifics.